(R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)(nitroso)amino)ethyl)phenyl)acetamide
|
(R)-2-(2-氨基噻唑-4-基)-N-(4-(2-((2-羥基-2-苯乙基)(亞硝基)氨基)乙基)苯基)乙酰胺
|
3017159-61-1
|
Landerol impurity M1-A
|
蘭地洛爾雜質(zhì)M1-A
|
|
Flurbiprofen menthol ester
|
氟比洛芬薄荷醇酯
|
|
TF-A-TS-TF4
|
TF-A-TS-TF4
|
|
Cefoxitin impurity E
|
頭孢西丁雜質(zhì)E
|
|
TF-R
|
TF-R
|
69032-07-1
|
Cefoxitin impurity F
|
頭孢西丁雜質(zhì)F
|
|
TF-J
|
TF-J
|
|
Narcotine
|
那可丁對照品
|
128-62-1
|
Dapoxetine hydrochloride A
|
鹽酸達(dá)泊西汀雜質(zhì)A
|
1346603-24-4
|
L(-)-Borneol
|
左旋龍腦
|
464-45-9
|
N-Nitroso-N-methylaniline
|
N-甲基-N-亞硝基苯胺
|
614-00-6
|
2-hydroxy-1,4-benzoquinone
|
2-羥基對苯醌
|
2474-72-8
|
2,3-Diaminonaphthalene
|
2,3-二氨基萘
|
771-97-1
|
Ornidazole Impurity F
|
奧硝唑雜質(zhì)F
|
14419-11-5
|
(-)-MAACKIAIN
|
高麗槐素對照品
|
19908-48-6
|
2-Bornene
|
2-莰烯(對照品)
|
464-17-5
|
Kushenol
|
苦參醇
|
97938-30-2
|
Salvianolic acid D
|
丹酚酸D
|
142998-47-8
|
atomoxetine hydrochloride impurity SM1-3
|
鹽酸托莫西汀雜質(zhì)SM1-3
|
21970-65-0
|
TRIFOLIRHIZIN
|
三葉豆紫檀苷對照品
|
6807-83-6
|
Non-corresponding isomer impurity 1
|
非對應(yīng)異構(gòu)體雜質(zhì)1
|
1821769-41-8
|
Ethyl 3-amino-3-oxopropanoate
|
氨基甲酰乙酸乙酯
|
7597-56-0
|
Loxoprofen Impurity L
|
洛索洛芬鈉雜質(zhì)L對照品
|
308279-38-1
|
Clarithromycin Impurity F
|
克拉霉素雜質(zhì)F 對照品
|
128940-83-0
|
4-Benzoylmorpholine
|
1468-28-6
|
Flurbiprofen Impurity 76
|
氟比洛芬雜質(zhì)76
|
1912791-27-5
|
3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester
|
3-(3R,4R)-3-(6,7-二氫-5H-吡咯并[2,3d]嘧啶-4-基x(甲基)氨基)4-甲基哌啶-1-基)-3-氧代丙酸]丁酯
|
2227199-31-5
|
N,4-dimethylpyridin-3-amine
|
N,4-二甲基吡啶-3-甲胺
|
77862-24-9
|
Flurbiprofen Related Compound A (Biprofen)
|
氟比洛芬相關(guān)物質(zhì)A
|
6341-72-6
|
5-(4-fluorophenyl)-5-oxovaleric acid
|
5-(4-氟苯基)-5-氧代戊酸
|
149437-76-3
|
Metaraminol Bitartrate Enantiomer C
|
重酒石酸間羥胺雜質(zhì)C對照品
|
27303-40-8
|
Diclofenac Impurity F
|
雙氯芬酸鈉雜質(zhì) F
|
560075-65-2
|
(S)-2-(2-((4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxoxazoliline-3-yl)phenyl)amino)ethoxy)acetic acid
|
(S)-2-(2-((4-(5-((5-氯噻吩-2-甲酰胺基)甲基)-2-氧代噁唑啉-3-基)苯基)氨基)乙氧基)乙酸
|
931204-39-6
|
2-(diphenoxymethyl)pyridine
|
2-(二苯氧基甲基)吡啶
|
105745-58-2
|
(S)-N-((R)-1-(naphthalen-1-yl)ethyl)pyrrolidin-3-amine
|
(S)-N-((R)-1-(萘-1-基)乙 基)吡咯烷-3-胺鹽酸鹽
|
870966-25-9
|
(E)-4-(3-nitrophenyl)butyl-3-en-2-one
|
(E)-4-(3-硝基苯基)丁-3-烯-2-酮
|
|
Finerenone decarboxyl-TH-naphthalene impurity
|
非奈利酮脫羧基-TH-萘啶雜質(zhì)
|
|
Clopidogrel Impurity
|
氯吡格雷雜質(zhì)
|
2173294-67-0
|
atomoxetine hydrochloride impurity SM1-8
|
鹽酸托莫西汀雜質(zhì)SM1-8
|
27152-62-1
|
atomoxetine hydrochloride impurity SM1-4
|
鹽酸托莫西汀雜質(zhì)SM1-4
|
74681-55-3
|
atomoxetine hydrochloride impurity I-11
|
鹽酸托莫西汀雜質(zhì)I-11
|
2659259-65-9
|
Betahistine Impurity B
|
倍他司汀雜質(zhì)B
|
103-74-2
|
Epinastine EP Impurity B
|
依匹斯汀EP雜質(zhì)B
|
1217052-16-8
|
2-chloropropanoyl chloride
|
2-氯丙酰氯
|
70110-24-6
|
NA
|
硫酸羥氯奎RS08
|
|
Gabexate mesylate Impurity 03
|
甲磺酸加貝酯雜質(zhì)03
|
2978626-53-6
|
Valsartan related compound H
|
纈沙坦雜質(zhì)H
|
|
Valsartan related compound F
|
纈沙坦雜質(zhì)F
|
|
Nafamostat mesylate impurity E
|
甲磺酸萘莫司他雜質(zhì)e
|
189016-90-8
|
Cefhydroxyl Capsule Impurity (Mmm-Phenylglycyl-Cefadroxil)
|
頭孢羥氨芐膠囊雜質(zhì)F(N-苯基甘氨酰-頭孢羥氨芐)
|
|
2-benzoquinone
|
2-苯醌
|
583-63-1
|
Cefotaxime impurity TBSW-IM-L
|
頭孢噻肟雜質(zhì)TBSW-IM-L
|
|
Cetirizine Impurity G
|
西替利嗪雜質(zhì)G
|
|
6-Amino-5-(2,2-diethoxyethyl)pyrimidin-4-ol
|
6-氨基-5-(2,2-二乙氧基乙基)-4-羥基嘧啶
|
007400-06-8
|
A-AMINO-A-IMINOETHANE ACETATE
|
乙酸乙脒
|
36896-17-0
|
Doltenol Impurity 5091-7F
|
多替諾德雜質(zhì)5091-7F
|
121-98-2
|
TF-P
|
托法替尼相關(guān)化合物35
|
2459302-85-1
|
BL-Impurity F
|
BL-雜質(zhì)F
|
76508-37-7
|
Sulfamoxole
|
磺胺二甲唑
|
729-99-7
|
BL-Impurity I
|
BL-雜質(zhì)I
|
76508-35-5
|
R-epichlorohydrin
|
(R)-(-)-環(huán)氧氯丙烷
|
51594-55-9
|
(4S)-(2,2-dimethyl-1,3-dioxolan-4-yl)-3-(4- hydroxybenzene) propanoic acid,methyl ester (Landiolol)
|
4S-(2,2-二甲基-1,3-二氧環(huán)戊烷-4-基)-3-(4-羥基苯基)丙酸酯 (蘭地洛爾)
|
144256-11-1
|
Benzotetramisole
|
苯并四咪唑
|
885051-07-0
|
Impurity API-IM11
|
雜質(zhì)API-IM11
|
2031255-23-7
|
Ciprofloxacin Impurity C
|
環(huán)丙沙星雜質(zhì)C
|
528851-31-2
|
Valsartan EP Impurity B
|
纈沙坦雜質(zhì)B
|
952652-79-8
|
Valsartan EP Impurity C
|
纈沙坦雜質(zhì)C
|
137863-20-8
|
Valsartan EP Impurity D
|
纈沙坦雜質(zhì)D
|
676129-92-3
|
Valsartan EP Impurity E
|
纈沙坦雜質(zhì)E
|
1111177-30-0
|
Butaphthalide impurity 63
|
丁苯酞雜質(zhì)63
|
1379356-37-2
|
Butaphthalide impurity 65
|
丁苯酞雜質(zhì)65
|
950681-33-1
|
Cefadroxil Capsule Impurity E (Diketopiperazine Derivative)
|
頭孢羥氨芐膠囊雜質(zhì)E(二酮哌嗪衍生物)
|
147103-93-3
|
N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
N-甲基-N-((3R,4R)-4-甲基-1-芐基-3-哌啶基)-7-((4-甲基苯基)磺?;?7H-吡咯并[2,3-D]嘧啶-4-胺 TF-5
|
923036-30-0
|
Berberine hydrochloride impurities
|
鹽酸小檗堿雜質(zhì)
|
7664-25-7
|
Dextromethorphan N-Oxide
|
右美沙芬雜質(zhì)氮氧化物
|
1177494-18-6
|
Dextromethorphan EP Impurity D
|
右美沙芬EP雜質(zhì)D
|
1453167-99-1
|
Ciprofloxacin Impurity D
|
環(huán)丙沙星雜質(zhì)D
|
526204-10-4
|
4-Amino-2,6-dichlorophenol
|
2,6-二氯-4-氨基苯酚
|
5930-28-9
|
Ozanimod hydrochloride impurity RP-101960
|
鹽酸奧扎莫德雜質(zhì)RP-101960
|
|
allylphosphonic acid
|
烯丙基膦酸
|
6833-67-6
|
Vildagliptin Impurity
|
維格列汀雜質(zhì)
|
006708-06-1
|
(Z)-Crotamiton
|
(z)-克羅米通
|
124236-30-2
|
Alprazolam impurity III
|
阿普唑侖雜質(zhì)III
|
|
Flurbiprofen Isopropyl Ester
|
氟比洛芬異丙酯
|
252846-89-2
|
Paclitaxel Impurity J
|
紫杉醇雜質(zhì)J
|
|
Ozanimod hydrochloride impurity RP-101990
|
鹽酸奧扎莫德雜質(zhì)RP-101990
|
|
Impurity B-4
|
雜質(zhì) B-4
|
|
Levothyroxine sodium impurity P
|
左甲狀腺素鈉雜質(zhì)P
|
|
Alprazolam Impurity IV
|
阿普唑侖雜質(zhì)IV
|
448950-89-8
|
3-Benzoylpyrrole
|
7126-41-2
|
l-Calcium pantothenate
|
L-泛酸鈣
|
6381-62-0
|
Ziprasidone Impurity 100972
|
齊拉西酮雜質(zhì)100972
|
1892546-95-0
|
Ethyl 2,3-difluoro-4-methylbenzoate
|
2,3-二氟-4-甲基苯甲酸乙酯
|
773135-56-1
|
TF-F
|
托法替布雜質(zhì)68
|
2641343-91-9
|
Aloxicillin polymer 4
|
阿洛西林聚合物4
|
|
3196 Impurities SM01-14
|
3196雜質(zhì)SM01-14
|
1903632-97-2
|
N,N′-Methylene bis-(2-amino-1,3,4-thiadiazole)
|
敵枯雙N,N'-Di(1,3,4-thiadiazo1-2-yl)methanediamine
|
26907-37-9
|
Butaphthalide impurity 66
|
丁苯酞雜質(zhì)66
|
950681-46-6
|
2-hydroxyphenyl acetate
|
乙酸2-羥基苯基酯對照品
|
2848-25-1
|